Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8506 |
High Similarity |
NPD37 |
Approved |
0.8462 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8462 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8462 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8282 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.825 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8151 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD1613 |
Approved |
0.811 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8037 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7898 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7755 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7712 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7665 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7639 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7616 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7564 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7564 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7457 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7457 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD6653 |
Approved |
0.745 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7417 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7399 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7346 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7341 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7303 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7268 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7262 |
Intermediate Similarity |
NPD919 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7208 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5585 |
Approved |
0.719 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7161 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD5401 |
Approved |
0.716 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7143 |
Intermediate Similarity |
NPD17 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7032 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7022 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7022
|
Intermediate Similarity |
NPD8312 |
Approved |